Repatha® (evolocumab) (NO LONGER ENROLLING)

This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out our information form by clicking the Make A Difference button below, and a member of our team will contact you.


Repatha® (evolocumab) (NO LONGER ENROLLING)

Help Us Better Understand the Tdap (“Whooping Cough”) Vaccine in Pregnancy

MotherToBaby is currently enrolling pregnant people in a study examining the use of the Tdap (tetanus, diphtheria, and pertussis) vaccine during pregnancy. All of our pregnancy research is observational and is conducted by phone — no changes to your normal routine or travel required.

“We believe our study results can help women and their doctors become better informed about the Tdap vaccine during pregnancy.”

— Christina Chambers, PhD, MPH, Lead Investigator, MotherToBaby Pregnancy Studies

Are you currently pregnant? Did you receive the Tdap vaccine at any point in your current pregnancy? If you answered “yes” to both of these questions, then you have the opportunity to help us learn more about the Tdap vaccine in pregnancy.

Will you take the step and become our partner? Make an impact on the health of future families today by joining our Tdap Vaccine & Pregnancy Study!


Repatha® (evolocumab) (NO LONGER ENROLLING)

This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in a study. Fill out your information using our Join a Study form, and a member of our team will contact you.


Repatha® (evolocumab) (NO LONGER ENROLLING)

This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in a study. Fill out your information using our Join a Study form, and a member of our team will contact you.


Repatha® (evolocumab) (NO LONGER ENROLLING)

This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.